Literature DB >> 12755996

Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells.

Kenji Nishimura1, Kiyomi Matsumiya, Hidenobu Miura, Akira Tsujimura, Norio Nonomura, Kunio Matsumoto, Toshikazu Nakamura, Akihiko Okuyama.   

Abstract

Urokinase-type plasminogen activator (uPA) and the uPA receptor (uPAR) are involved in a proteolytic cascade resulting of extracellular matrix degradation. Upstream, uPA and uPAR are regulated by various factors including hepatocyte growth factor (HGF), which stimulates the uPA/uPAR proteolytic system and increases invasion of cancers. We recently demonstrated that HGF induces invasion of DU145 prostate cancer cells into collagen gel matrix. We therefore examined effects of HGF on uPA and uPAR expression in DU145 cells. Effects of HGF on uPA expression in culture medium were determined by Western blotting and fibrin zymography, effects on uPAR expression in cell-associated protein were examined by Western blotting. HGF increased uPA and uPAR production in a dose-dependent manner up to 10 ng/mL, while effects of 20 ng/mL were approximately equal to those of 10 ng/mL. HGF stimulated uPA production beyond that in control cultures from 8 h until 48 h after HGF addition. HGF stimulated a uPA/uPAR proteolytic network in DU145 cells, which may be important for acquisition invasive potential by prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12755996     DOI: 10.1046/j.1365-2605.2003.00413.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  7 in total

1.  Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.

Authors:  P Elumalai; A Brindha Mercy; R Arunkamar; G Sharmila; F A Bhat; S Balakrishnan; P Raja Singh; J Arunakaran
Journal:  Cell Prolif       Date:  2014-12       Impact factor: 6.831

2.  RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Authors:  Sai MuraliKrishna Pulukuri; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Norman Estes; Meena Gujrati; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

3.  Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms.

Authors:  Suraj Kachgal; Andrew J Putnam
Journal:  Angiogenesis       Date:  2010-11-21       Impact factor: 9.596

4.  Prostate cancer cell surface-associated keratin 8 and its implications for enhanced plasmin activity.

Authors:  Melissa Hirsch Kuchma; Joo Hee Kim; Mark T Muller; Philip A Arlen
Journal:  Protein J       Date:  2012-03       Impact factor: 2.371

Review 5.  Tumor stroma as targets for cancer therapy.

Authors:  Jing Zhang; Jinsong Liu
Journal:  Pharmacol Ther       Date:  2012-10-12       Impact factor: 12.310

6.  Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.

Authors:  Amanda Tate; Shuji Isotani; Michael J Bradley; Robert A Sikes; Rodney Davis; Leland W K Chung; Magnus Edlund
Journal:  BMC Cancer       Date:  2006-07-25       Impact factor: 4.430

7.  Docosahexaenoic Acid Inhibits Tumor Promoter-Induced Urokinase-Type Plasminogen Activator Receptor by Suppressing PKCδ- and MAPKs-Mediated Pathways in ECV304 Human Endothelial Cells.

Authors:  Sen Lian; Yong Xia; Thi Thinh Nguyen; Trong Thuan Ung; Hyun Joong Yoon; Nam Ho Kim; Kyung Keun Kim; Young Do Jung
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.